10.
Kavanaugh A, Fleischmann RM, Emery P, et al. Clinical, functional and radiographic consequences of achieving stable low disease activity and remission with adalimumab plus methotrexate or methotrexate alone in early rheumatoid arthritis: 26 week results from the randomised, controlled OPTIMA study. Ann Rheum Dis 2013; 72: 64-71.